These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37350063)

  • 1. NFE2L3 drives hepatocellular carcinoma cell proliferation by regulating the proteasome-dependent degradation of ISGylated p53.
    Ren Y; Yang J; Ding Z; Zheng M; Qiu L; Tang A; Huang D
    Cancer Sci; 2023 Sep; 114(9):3523-3536. PubMed ID: 37350063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short hairpin RNA-mediated knockdown of nuclear factor erythroid 2-like 3 exhibits tumor-suppressing effects in hepatocellular carcinoma cells.
    Yu MM; Feng YH; Zheng L; Zhang J; Luo GH
    World J Gastroenterol; 2019 Mar; 25(10):1210-1223. PubMed ID: 30886504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NRF3-POMP-20S Proteasome Assembly Axis Promotes Cancer Development via Ubiquitin-Independent Proteolysis of p53 and Retinoblastoma Protein.
    Waku T; Nakamura N; Koji M; Watanabe H; Katoh H; Tatsumi C; Tamura N; Hatanaka A; Hirose S; Katayama H; Tani M; Kubo Y; Hamazaki J; Hamakubo T; Watanabe A; Murata S; Kobayashi A
    Mol Cell Biol; 2020 Apr; 40(10):. PubMed ID: 32123008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NFE2L1 and NFE2L3 Complementarily Maintain Basal Proteasome Activity in Cancer Cells through CPEB3-Mediated Translational Repression.
    Waku T; Katayama H; Hiraoka M; Hatanaka A; Nakamura N; Tanaka Y; Tamura N; Watanabe A; Kobayashi A
    Mol Cell Biol; 2020 Jun; 40(14):. PubMed ID: 32366381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleophosmin (NPM1/B23) interacts with activating transcription factor 5 (ATF5) protein and promotes proteasome- and caspase-dependent ATF5 degradation in hepatocellular carcinoma cells.
    Liu X; Liu D; Qian D; Dai J; An Y; Jiang S; Stanley B; Yang J; Wang B; Liu X; Liu DX
    J Biol Chem; 2012 Jun; 287(23):19599-609. PubMed ID: 22528486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression.
    Wang C; Qi R; Li N; Wang Z; An H; Zhang Q; Yu Y; Cao X
    J Biol Chem; 2009 Jun; 284(24):16183-16190. PubMed ID: 19376776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
    Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X
    BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rpn10 promotes tumor progression by regulating hypoxia-inducible factor 1 alpha through the PTEN/Akt signaling pathway in hepatocellular carcinoma.
    Jiang Z; Zhou Q; Ge C; Yang J; Li H; Chen T; Xie H; Cui Y; Shao M; Li J; Tian H
    Cancer Lett; 2019 Apr; 447():1-11. PubMed ID: 30673593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stringent Control of NFE2L3 (Nuclear Factor, Erythroid 2-Like 3; NRF3) Protein Degradation by FBW7 (F-box/WD Repeat-containing Protein 7) and Glycogen Synthase Kinase 3 (GSK3).
    Kannan MB; Dodard-Friedman I; Blank V
    J Biol Chem; 2015 Oct; 290(43):26292-302. PubMed ID: 26306035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The homeobox transcription factor Prox1 inhibits proliferation of hepatocellular carcinoma cells by inducing p53-dependent senescence-like phenotype.
    Chang TM; Hung WC
    Cancer Biol Ther; 2013 Mar; 14(3):222-9. PubMed ID: 23291986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of NFE2L3 promotes the development of gastric cancer through epithelial-mesenchymal transformation.
    Wang X; Li Y; Fang Z; Li Y
    Bioengineered; 2021 Dec; 12(2):12204-12214. PubMed ID: 34783304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSMD4 drives progression of hepatocellular carcinoma via Akt/COX2 pathway and p53 inhibition.
    Zhang J; Fang S; Rong F; Jia M; Wang Y; Cui H; Hao P
    Hum Cell; 2023 Sep; 36(5):1755-1772. PubMed ID: 37336868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53.
    Cao P; Yang A; Wang R; Xia X; Zhai Y; Li Y; Yang F; Cui Y; Xie W; Liu Y; Liu T; Jia W; Jiang Z; Li Z; Han Y; Gao C; Song Q; Xie B; Zhang L; Zhang H; Zhang J; Shen X; Yuan Y; Yu F; Wang Y; Xu J; Ma Y; Mo Z; Yu W; He F; Zhou G
    Gastroenterology; 2018 Aug; 155(2):542-556. PubMed ID: 29702115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway.
    Zhao J; Wozniak A; Adams A; Cox J; Vittal A; Voss J; Bridges B; Weinman SA; Li Z
    J Exp Clin Cancer Res; 2019 Jun; 38(1):252. PubMed ID: 31196136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
    Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
    J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin regulates the proliferation of Huh7, a hepatocellular carcinoma cell line, by up-regulating p53 expression.
    Kwon S; Jeon JS; Ahn C; Sung JS; Choi I
    Biochem Biophys Res Commun; 2016 Oct; 479(1):74-9. PubMed ID: 27616194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF-1 promotes the growth and metastasis of hepatocellular carcinoma via the inhibition of proteasome-mediated cathepsin B degradation.
    Lei T; Ling X
    World J Gastroenterol; 2015 Sep; 21(35):10137-49. PubMed ID: 26401078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PSMD11 promotes the proliferation of hepatocellular carcinoma by regulating the ubiquitination degradation of CDK4.
    Sun L; Liu Z; Wu Z; Wu Z; Qiu B; Liu S; Hu J; Yin X
    Cell Signal; 2024 Sep; 121():111279. PubMed ID: 38944255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSG101 promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by regulating the PEG10.
    Liu Z; Tian Z; Cao K; Zhang B; Wen Q; Zhou X; Yang W; Wang T; Shi H; Wang R
    J Cell Mol Med; 2019 Jan; 23(1):70-82. PubMed ID: 30450735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53.
    Kuo TC; Chang PY; Huang SF; Chou CK; Chao CC
    Biochem Pharmacol; 2012 Mar; 83(6):758-68. PubMed ID: 22230478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.